Cerebral aspergillosis is associated with very high mortality in immunocompromised hosts. Conventional antifungal agents like amphotericin-B and itraconazole are almost ineffective in cerebral aspergillosis. Newer azoles have been shown to penetrate the blood, cerebrospinal fluid barrier and achieve effective fungicidal concentrations. These newer azoles may change the outlook of this fatal condition. We report here a patient with cerebral aspergillosis who was successfully treated with voriconazole.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1365-2257.2006.00737.x | DOI Listing |
Publication Analysis
Top Keywords
cerebral aspergillosis
12
treated voriconazole
8
newer azoles
8
aspergillus brain
4
brain abscess
4
abscess patient
4
patient acute
4
acute myeloid
4
myeloid leukaemia
4
leukaemia treated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!